XRTX
XORTX Therapeutics, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website xortx.com
- Employees(FY) 3
- ISIN CA98420Q3061
Performance
-0.96%
1W
-20.16%
1M
-53.71%
3M
-10.04%
6M
-10.82%
YTD
-65.88%
1Y
Profile
XORTX Therapeutics Inc., a late stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, diabetes, insulin resistance, metabolic syndrome, diabetes, diabetic nephropathy, and infection. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic kidney disease; XRx-101, an uric acid lowering agent used to treat patients infected with the coronavirus COVID-19 infection and acute kidney injury (AKI) associated health consequences; and XRX-225, a program for treatment of type 2 diabetic nephropathy. The company has a collaboration and license agreements with the Icahn School of Medicine to study the incidence of AKI and hyperuricemia in patients hospitalized with COVID-19; and with the University of Florida Research Foundation, Inc. XORTX Therapeutics Inc. is based in Alberta Beach, Canada.
Technical Analysis of XRTX 2024-05-31
Overview:
In analyzing the technical indicators for XRTX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions for informed deci...
Recent News & Updates
- 2022-08-03 19:00
- 2022-07-21 20:00
XORTX Reports Annual & Special Meeting Results(Yahoo Finance)
- 2022-07-18 19:00
XORTX Announces Submission to European Medicines Agency(Yahoo Finance)
- 2022-07-12 19:00
- 2022-07-06 19:00
- 2022-06-20 19:00
XORTX Announces Fireside Chat with XORTX CEO(Yahoo Finance)
- 2022-06-12 20:55
XORTX to Present at BIO International Convention 2022(Yahoo Finance)
- 2022-06-07 19:00
XORTX to Present at LD Micro Invitational 2022(Yahoo Finance)
- 2022-06-05 19:00
- 2022-05-24 20:00
- 2022-05-04 19:00
- 2022-05-02 19:00
- 2022-04-19 19:00
- 2022-04-11 19:00
XORTX Receives No Objection Letter from Health Canada(Yahoo Finance)
- 2022-04-06 19:00
XORTX Announces Grant of US Patent(Yahoo Finance)
- 2022-03-30 19:00
XORTX Files IND with US FDA(Yahoo Finance)
- 2022-03-22 19:00
- 2022-03-13 19:00
- 2022-01-30 18:00
XORTX Provides Corporate Update(Yahoo Finance)
- 2022-01-19 18:00
XORTX Announces Appointment of Chief Technology Officer(Yahoo Finance)
- 2022-01-11 19:30
- 2022-01-09 18:00
- 2021-12-21 19:30
- 2021-12-21 05:00
XORTX Reports Annual & Special Meeting Results(Yahoo Finance)
- 2021-12-20 18:00
- 2021-12-09 18:01
- 2021-12-08 22:53
- 2021-12-08 20:30
TMX Group Equity Financing Statistics - November 2021(Yahoo Finance)
- 2021-12-08 19:04
- 2021-12-01 18:00